Spyre Therapeutics, Inc. (SYRE)
(Real Time Quote from BATS)
$37.11 USD
-0.69 (-1.83%)
Updated May 17, 2024 11:52 AM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/09/2024
Time: -- |
6/2024 | $-0.90 | -21.22% |
Earnings Summary
For their last quarter, Spyre Therapeutics, Inc. (SYRE) reported earnings of -$1.20 per share, missing the Zacks Consensus Estimate of -$0.90 per share. This reflects a negative earnings surprise of 33.33%. Look out for SYRE's next earnings release expected on August 09, 2024. For the next earning release, we expect the company to report earnings of -$0.90 per share, reflecting a year-over-year increase of 97.83%.
Earnings History
Price & Consensus
Zacks News for SYRE
Here's Why Spyre Therapeutics (SYRE) Could be Great Choice for a Bottom Fisher
SYRE: What are Zacks experts saying now?
Zacks Private Portfolio Services